Global Bipolar Depression Epidemiology Forecast 2017-2030

The “Bipolar Depression – Epidemiology Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering….

The “Bipolar Depression – Epidemiology Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

The Bipolar Depression – Epidemiology Forecast-2030′ report delivers an in-depth understanding of the Bipolar Depression, historical and forecasted epidemiology as well as the Bipolar Depression trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Bipolar Depression Detailed Epidemiology Segmentation

  • As per the analysts, the total diagnosed prevalent population of Bipolar Depression in the 7MM was 1,857,545 in 2017.

  • The estimates show the highest diagnosed prevalence of Bipolar Depression in the United States with 740,715 cases.

  • Bipolar I and Bipolar II are the major subtypes of BD. In 2017, out of the total diagnosed prevalent population of 740,715 cases in the US for Bipolar Depression, 291,134 and 449,581 cases were contributed by Bipolar I disorder and Bipolar II disorder, respectively.

  • Based on the severity of the Bipolar Depression, total diagnosed prevalent cases are categorized into mild, moderate and severe. In 2017, out of the total diagnosed prevalent population in the US for Bipolar Depression, 28,666 cases were mild, 158,735 cases were moderate, and 553,092 cases were severe.

  • Among the European five countries, France had the highest diagnosed population of Bipolar Depression with 278,145 cases, followed by Germany and the UK. On the other hand, Spain had the lowest diagnosed prevalent population of 89,599 cases in 2017.

  • Total diagnosed prevalent cases of Bipolar Depression in Japan were found to be 210,902 in 2017.

Key Topics Covered:

1. Key Insights

2. Executive Summary of Bipolar Depression

4. Disease Background and Overview: Bipolar Depression

4.1. Introduction

4.2. Classification of Bipolar Disorder According to DSM-5

4.3. Symptoms

4.4. Causes

4.5. Risk Factors

4.6. Pathophysiology

4.7. Genetics Findings in Bipolar Disorder

4.8. Biomarkers

4.9. Diagnosis

4.9.1.Diagnostic Guidelines

5. Epidemiology and Patient Population

5.1. Key Findings

5.2. KOL Views

5.3. Epidemiology Methodology

5.4. Total Diagnosed Prevalent Cases of Bipolar Depression in the 7MM

6. United States Epidemiology

6.1. Assumptions and Rationale

6.2. Total Diagnosed Prevalent Cases of Bipolar Depression in the United States

6.3. Type-specific Diagnosed Prevalent Cases of Bipolar Depression in the United States

6.4. Severity-specific Diagnosed Prevalent cases of Bipolar Depression in the United States

7. EU5 Epidemiology

8. Japan Epidemiology

9. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/2w0sfq

View source version on businesswire.com: https://www.businesswire.com/news/home/20201009005279/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900